Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
+16.79%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$205B
AUM Growth
+$205B
Cap. Flow
+$7.55B
Cap. Flow %
3.68%
Top 10 Hldgs %
37.27%
Holding
484
New
38
Increased
175
Reduced
104
Closed
12

Sector Composition

1 Consumer Discretionary 29.73%
2 Healthcare 22.49%
3 Technology 18.75%
4 Communication Services 13.22%
5 Financials 4.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CVGW icon
451
Calavo Growers
CVGW
$488M
$7K ﹤0.01% 113
HI icon
452
Hillenbrand
HI
$1.79B
$7K ﹤0.01% 170
OXM icon
453
Oxford Industries
OXM
$658M
$7K ﹤0.01% 73
SEER icon
454
Seer Inc
SEER
$115M
$7K ﹤0.01% 223
ZYXI icon
455
Zynex
ZYXI
$49.7M
$7K ﹤0.01% 437
AFIB
456
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
$7K ﹤0.01% 424
ATRI
457
DELISTED
Atrion Corp
ATRI
$6K ﹤0.01% 9
VRAY
458
DELISTED
ViewRay, Inc.
VRAY
$6K ﹤0.01% 911
XENT
459
DELISTED
Intersect ENT, Inc
XENT
$6K ﹤0.01% 361
AGX icon
460
Argan
AGX
$3.11B
$5K ﹤0.01% 103
ALKS icon
461
Alkermes
ALKS
$4.78B
$5K ﹤0.01% 192
FOLD icon
462
Amicus Therapeutics
FOLD
$2.34B
$5K ﹤0.01% 538
HCSG icon
463
Healthcare Services Group
HCSG
$1.13B
$5K ﹤0.01% 157
HRTX icon
464
Heron Therapeutics
HRTX
$207M
$5K ﹤0.01% 308
AXDX
465
DELISTED
Accelerate Diagnostics
AXDX
$3K ﹤0.01% 418
QTTB icon
466
Q32 Bio
QTTB
$20.9M
$3K ﹤0.01% 481
AAOI icon
467
Applied Optoelectronics
AAOI
$1.51B
$2K ﹤0.01% 260
AMRX icon
468
Amneal Pharmaceuticals
AMRX
$3B
$2K ﹤0.01% 452
PBYI icon
469
Puma Biotechnology
PBYI
$254M
$2K ﹤0.01% 252
ICPT
470
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01% 101
CLVS
471
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01% 92
BGT icon
472
BlackRock Floating Rate Income Trust
BGT
$319M
-784,230 Closed -$9.81M
EB icon
473
Eventbrite
EB
$256M
-3,908,734 Closed -$86.6M
EFX icon
474
Equifax
EFX
$30.3B
-52 Closed -$9K
EXTR icon
475
Extreme Networks
EXTR
$2.83B
-687 Closed -$6K